Zacks Investment Research
16 Mar 2026, 14:45 UTC · 28w ago
Verdict
Headline takes no side. We score IART +0.20 across four claims — slightly bullish.
+0.20slightly bullish
More positive than 57% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Integra LifeSciences stock has lost 60% of its value over the past year, drastically underperforming both its industry (-8.5%) and the S&P 500 (20.1%).
So whatA 60% drawdown signals severe loss of investor confidence and potentially distressed valuation, heavily negative for current shareholders and risk appetite.
More negative than 99% of claims this week
Integra faces macroeconomic challenges and unfavorable liquidity that raise concerns for the company's financial stability.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 98% of claims this week
Integra's Codman Specialty Surgical segment is experiencing healthy demand and solid results, driven by double-digit performance in key neurosurgery and ENT products.
So whatStrong organic growth and market share gains in the core business provide a material positive offset to the company's broader financial and macro challenges.
More positive than 87% of claims this week
Integra is successfully expanding its international footprint, with double-digit growth in markets like China and Canada bolstering its CSS business.
More positive than 74% of claims this week
Which stocks this story touches
More positive than 57% of ticker scores this week
The company shows healthy demand in its CSS segment and successful international expansion, despite macroeconomic challenges and a significant stock price drop.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
+75.1%
Price agrees with the score
$16.18 vs $9.24 close before publication (Mar 13) · not market-adjusted
IART chart →
